MOLECULE |
STATUS |
MOLECULE |
STATUS |
AMLODIPINE + RAMIPRIL |
READY TO BE SUBMITTED |
NAPROXEN EC |
READY TO BE SUBMITTED |
ARIPIPRAZOL |
READY TO BE SUBMITTED QIII 2013 |
NITROGLYCERINE |
AUTHORISED |
CILOSTAZOL |
READY TO BE SUBMITTED QIII 2012 |
OLANZAPINE |
AUTHORISED |
CLOPIDOGREL |
PENDING APPLICATION |
OLANZAPINE ORODISPERSIBLE |
AUTHORISED |
CINACALCET |
READY TO BE SUBMITTED QI 2013 |
OLMESARTAN |
READY TO BE SUBMITTED Q3/2012 |
DONEPEZIL |
AUTHORISED |
OLMESARTAN +HCTZ |
READY TO BE SUBMITTED Q3/2012 |
DULOXETINE |
READY TO BE SUBMITTED QI 2013 |
REPAGLINIDE |
READY TO BE SUBMITTED |
EPLERENONE I. |
READY TO BE SUBMITTED |
RISEDRONATE |
AUTHORISED |
ESCITALOPRAM |
READY TO BE SUBMITTED |
RIZATRIPTAN BENZOATE |
READY TO BE SUBMITTED 2013 |
ESOMEPRAZOLE |
READY TO BE SUBMITTED |
RIZATRIPTAN BENZOATE ODT |
READY TO BE SUBMITTED 2013 |
FURAZIDINE |
READY TO BE SUBMITTED |
ROSUVASTATINE |
READY TO BE SUBMITTED QIV 2013 |
IMATINIB |
READY TO BE SUBMITTED |
SILDENAFIL |
PENDING APPLICATION |
IRBESARTAN |
PENDING APPLICATION |
TELMISARTAN |
READY TO BE SUBMITTED |
IRBESARTAN + HYDROCHLOROTIAZIDE |
READY TO BE SUBMITTED |
TELMISARTAN HCTZ |
READY TO BE SUBMITTED |
LEVETIRACETAM |
AUTHORISED |
VALSARTAN |
AUTHORISED |
LEVOFLOXACINE |
AUTHORISED |
VALSARTAN + HYDROCHLOROTIAZIDE |
PENDING APPLICATION |
LINEZOLID |
READY TO BE SUBMITTED |
ZALEPLON |
READY TO BE SUBMITTED |
MONTELUKAST |
AUTHORISED |
ZOLMITRIPTAN |
READY TO BE SUBMITTED |